Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tilmann Bochtler

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Cell Cycle (Georgetown, Tex.)|August 30, 2007
DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint functionHarald Löffler, Tilmann Bochtler, Britta Fritz, et al.
European Journal of Haematology|August 12, 2017
Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemiaWenwen Wang, Tilmann Bochtler, Patrick Wuchter, et al.
Blood|November 23, 2011
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patientsStefan O Schönland, Ute Hegenbart, Tilmann Bochtler, et al.
Cold Spring Harbor Molecular Case Studies|September 15, 2016
Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemiaTilmann Bochtler, Stefan Fröhling, Wilko Weichert, et al.
Genes, Chromosomes & Cancer|November 10, 2018
Micronucleus formation in human cancer cells is biased by chromosome sizeTilmann Bochtler, Mutlu Kartal-Kaess, Martin Granzow, et al.
Blood|May 28, 2017
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosisTobias Dittrich, Tilmann Bochtler, Christoph Kimmich, et al.
Clinical Chemistry|January 4, 2024
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown PrimaryMaria Pouyiourou, Tilmann Bochtler, Cornelia Coith, et al.
Haematologica|March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysisMartin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 12, 2021
Cryostorage to What End? - Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm PatientsKatharina Kriegsmann, Petra Pavel, Tilmann Bochtler, et al.
Genes, Chromosomes & Cancer|April 17, 2022
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primaryTilmann Bochtler, Timothy Wohlfromm, Thomas Hielscher, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Cell Cycle (Georgetown, Tex.)|August 30, 2007
DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint functionHarald Löffler, Tilmann Bochtler, Britta Fritz, et al.
European Journal of Haematology|August 12, 2017
Mesenchymal stromal cells contribute to quiescence of therapy-resistant leukemic cells in acute myeloid leukemiaWenwen Wang, Tilmann Bochtler, Patrick Wuchter, et al.
Blood|November 23, 2011
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patientsStefan O Schönland, Ute Hegenbart, Tilmann Bochtler, et al.
Cold Spring Harbor Molecular Case Studies|September 15, 2016
Evolution of a FLT3-TKD mutated subclone at meningeal relapse in acute promyelocytic leukemiaTilmann Bochtler, Stefan Fröhling, Wilko Weichert, et al.
Genes, Chromosomes & Cancer|November 10, 2018
Micronucleus formation in human cancer cells is biased by chromosome sizeTilmann Bochtler, Mutlu Kartal-Kaess, Martin Granzow, et al.
Blood|May 28, 2017
AL amyloidosis patients with low amyloidogenic free light chain levels at first diagnosis have an excellent prognosisTobias Dittrich, Tilmann Bochtler, Christoph Kimmich, et al.
Clinical Chemistry|January 4, 2024
Frequency and Prognostic Value of Circulating Tumor Cells in Cancer of Unknown PrimaryMaria Pouyiourou, Tilmann Bochtler, Cornelia Coith, et al.
Haematologica|March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysisMartin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 12, 2021
Cryostorage to What End? - Autologous Stem Cell Products in Burkitt Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Myeloproliferative Neoplasm PatientsKatharina Kriegsmann, Petra Pavel, Tilmann Bochtler, et al.
Genes, Chromosomes & Cancer|April 17, 2022
Prognostic impact of copy number alterations and tumor mutational burden in carcinoma of unknown primaryTilmann Bochtler, Timothy Wohlfromm, Thomas Hielscher, et al.
Pageof 6